Northwestern Scientists Discover Fructose Metabolism Pathway Drives Glioblastoma Growth and Immune Suppression
核心洞察
Northwestern Medicine researchers identified that brain-resident microglia cells uniquely metabolize fructose through the GLUT5 (搜索) transporter to suppress immune responses and promote glioblastoma (搜索) tumor growth.
Removing the fructose transporter in mouse models prevented tumor growth entirely and activated cancer-killing CD8+ T-cells (搜索), suggesting a novel therapeutic target for brain cancer (搜索) treatment.
The findings reveal that fructose acts differently in the brain compared to other organs, suppressing rather than promoting inflammation, opening new avenues for improving immunotherapy responses in glioblastoma (搜索) patients.
Northwestern Medicine scientists have made a groundbreaking discovery that could revolutionize treatment approaches for glioblastoma (搜索), the most aggressive form of brain cancer (搜索). Their research, published March 17 in the Proceedings of the National Academy of Sciences, reveals that specialized immune cells within brain tumors hijack fructose metabolism to suppress immune responses and fuel tumor growth.
The study represents the first identification of fructose metabolism as a driver of immune suppression in brain tumors, offering a promising new therapeutic target for a cancer that has seen little progress in treatment options over the past two decades.
Dramatic Results in Mouse Models
"Across several mouse models, when we removed the fructose transporter, the tumors simply didn't grow," said study senior author Jason Miska, assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine. "It was far more dramatic than we anticipated."
Glioblastoma (搜索) maintains a devastating five-year survival rate of less than 7%, according to the National Brain Tumor Society (搜索). The tumor's resistance to treatment stems partly from its complex microenvironment, which includes immunosuppressive myeloid cells and brain-resident microglia that normally protect the central nervous system.
Unique Fructose Pathway in Brain Immune Cells
The research team discovered that microglia express a unique fructose transporter called GLUT5 (搜索), which enables them to transport and metabolize fructose. Through comprehensive analysis using flow cytometry and genetic sequencing methods, the scientists confirmed that microglia are the only immune cells in the glioblastoma (搜索) microenvironment capable of metabolizing fructose.
"We knew microglia use this fructose transporter as part of their normal biology, but we did not expect it to be this important for brain tumor growth," said Miska, who is also a member of the Robert H. Lurie Comprehensive Cancer Center (搜索) of Northwestern University.
Enhanced Immune Response Without Fructose Metabolism
When researchers studied tumors in mice genetically engineered without the GLUT5 (搜索) transporter, they observed dramatically enhanced immune responses. These included better tumor cell recognition, increased production of inflammatory cytokines, and rapid multiplication of CD8+ T-cells (搜索), the immune system's primary cancer-killing cells.
"This not only makes the microglia themselves more inflammatory, but it also causes those T-cells and B-cells that are in the tumor to be more activated and create more inflammatory molecules that we have shown are required for rejection of brain tumors," explained Leah Billingham, a Northwestern postdoctoral fellow and co-first author of the study.
Brain-Specific Fructose Effects
The findings reveal a paradoxical role for fructose in brain tissue compared to other organ systems. While increased fructose consumption is associated with inflammatory diseases including colon cancer (搜索) and diabetic neuropathy (搜索), in the brain, fructose appears to suppress inflammation.
"Fructose consumption is associated with so many bad inflammatory outcomes in patients. What's interesting here is that in the brain, it seems to be working differently," Miska noted. "It still helps the brain tumor grow, but now we're seeing something very different in the brain than we see in the rest of the body."
Therapeutic Implications and Future Directions
The discovery suggests that microglial fructose metabolism serves as a key regulator of immune suppression in glioblastoma (搜索) and represents a promising therapeutic target for improving immunotherapy responses in patients.
"The challenge with glioblastoma (搜索) is that the standard of care has barely changed in 20 years," Miska said. "That's why identifying an entirely new therapeutic approach like this is so exciting."
The research team now aims to identify drugs capable of blocking fructose transport for testing in preclinical trials. "Once we can get our hands on something that is promising as a fructose transport inhibitor, we will then take it into preclinical stages where we add standard-of-care therapies for brain tumors or immunotherapies and see if we can sensitize them," Miska explained.
The unexpected nature of these findings, first observed nearly four years ago, has driven the team's continued investigation into this novel pathway. The research opens new possibilities for combination therapies that could finally improve outcomes for patients facing this devastating diagnosis.